Read More Pharma Industry News Protagonist Therapeutics secures $22m to advance IBD treatment Protagonist Therapeutics, a clinical-stage biopharmaceutical company specializing in the discovery and development of novel peptide-based drugs, has successfully… bypharmanewsdailyAugust 6, 2018